Dropout from exercise trials among cancer survivors—An individual patient data meta-analysis from the POLARIS studyNetherlands Cancer Institute, Amsterdam, Netherlands.
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Netherlands Cancer Institute, Amsterdam, Netherlands; Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Central Institute of Mental Health, Mannheim, Germany; University Of Heidelberg, Heidelberg, Germany; University of Antwerp, Antwerpen, Belgium.
Loughborough University, Loughborough, United Kingdom.
Edith Cowan University, Perth, Australia.
King's College London, London, United Kingdom.
University of Groningen, Groningen, Netherlands; University Medical Center Groningen, Groningen, Netherlands.
George Washington University, Washington, D.C., United States.
Netherlands Cancer Institute, Amsterdam, Netherlands; University of Twente, Enschede, Netherlands.
Queensland University of Technology, Brisbane, Australia.
Fundación Giafys Cancer, Miranda de Ebro, Spain.
University Medical Center Utrecht, Utrecht, Netherlands.
Yale University, New Haven, United States.
The University of Newcastle, Newcastle, New South Wales, Australia.
Amsterdam University Medical Center, Amsterdam, Netherlands.
University of Amsterdam, Amsterdam, Netherlands.
University Medical Center Utrecht, Utrecht, Netherlands.
University of Edinburgh, Edinburgh, United Kingdom.
University of Amsterdam, Amsterdam, Netherlands; Amsterdam Movement Sciences, Amsterdam, Netherlands.
Netherlands Cancer Institute, Amsterdam, Netherlands; Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
German Cancer Research Center, Heidelberg, Germany.
University of Pittsburgh, Pittsburgh, United States.
University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany.
University of Melbourne, Melbourne, Australia.
German Cancer Research Center, Heidelberg, Germany.
Oslo University Hospital, Oslo, Norway; Oslo University Hospital, Oslo, Norway.
Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands.
Johns Hopkins University School of Medicine, Baltimore, United States.
Oregon Health and Science University, Portland, United States.
University of Agder, Kristiansand, Norway.
Radboud University Medical Center, Nijmegen, Netherlands.
Show others and affiliations
2024 (English)In: Scandinavian Journal of Medicine and Science in Sports, ISSN 0905-7188, E-ISSN 1600-0838, Vol. 34, no 2, p. 1-10, article id e14575Article in journal (Refereed) Published
Abstract [en]
Introduction: The number of randomized controlled trials (RCTs) investigating the effects of exercise among cancer survivors has increased in recent years; however, participants dropping out of the trials are rarely described. The objective of the present study was to assess which combinations of participant and exercise program characteristics were associated with dropout from the exercise arms of RCTs among cancer survivors. Methods: This study used data collected in the Predicting OptimaL cAncer RehabIlitation and Supportive care (POLARIS) study, an international database of RCTs investigating the effects of exercise among cancer survivors. Thirty-four exercise trials, with a total of 2467 patients without metastatic disease randomized to an exercise arm were included. Harmonized studies included a pre and a posttest, and participants were classified as dropouts when missing all assessments at the post-intervention test. Subgroups were identified with a conditional inference tree. Results: Overall, 9.6% of the participants dropped out. Five subgroups were identified in the conditional inference tree based on four significant associations with dropout. Most dropout was observed for participants with BMI >28.4 kg/m2, performing supervised resistance or unsupervised mixed exercise (19.8% dropout) or had low-medium education and performed aerobic or supervised mixed exercise (13.5%). The lowest dropout was found for participants with BMI >28.4 kg/m2 and high education performing aerobic or supervised mixed exercise (5.1%), and participants with BMI ≤28.4 kg/m2 exercising during (5.2%) or post (9.5%) treatment. Conclusions: There are several systematic differences between cancer survivors completing and dropping out from exercise trials, possibly affecting the external validity of exercise effects. © 2024 The Authors. Scandinavian Journal of Medicine & Science In Sports published by John Wiley & Sons Ltd.
Place, publisher, year, edition, pages
Chichester, West Sussex: Wiley-Blackwell Publishing Inc., 2024. Vol. 34, no 2, p. 1-10, article id e14575
Keywords [en]
cancer, decision tree, exercise oncology, individual patient data meta-analysis
National Category
Health Sciences Cancer and Oncology
Research subject
Health Innovation, M4HP
Identifiers
URN: urn:nbn:se:hh:diva-52759DOI: 10.1111/sms.14575ISI: 001161498500001PubMedID: 38339809Scopus ID: 2-s2.0-85184793553OAI: oai:DiVA.org:hh-52759DiVA, id: diva2:1841037
Note
The present study was part of a PhD project funded by the South‐Eastern Norway Regional Health Authority. The POLARIS study is supported by the Bas Mulder Award, granted to L. M. Buffart by the Alpe d’HuZes foundation/Dutch Cancer Society (VU2011–5045).
2024-02-272024-02-272024-05-06Bibliographically approved